TY - JOUR
T1 - Safety and efficacy of microfocused ultrasound in tightening of lax elbow skin
AU - Rokhsar, Cameron
AU - Schnebelen, Wendy
AU - West, Alexandre
AU - Hornfeldt, Carl
N1 - Publisher Copyright:
© 2015 by the American Society for Dermatologic Surgery, Inc.
PY - 2015/7/9
Y1 - 2015/7/9
N2 - BACKGROUNDWith the increased popularity of minimally invasive cosmetic treatments, this study evaluates the efficacy and safety of microfocused ultrasound with visualization (MFU-V) for tightening lax skin above the elbow.METHODSSubjects were treated bilaterally above the elbows with MFU-V using transducers with different focal depths. Photographs were taken before treatment and at 90- and 180-day follow-ups. Masked observer ratings and physician and subject global aesthetic improvement scales (PGAIS and SGAIS) were completed at follow-ups. Safety, based on adverse event (AE) incidence, was assessed.RESULTSMasked blinded assessment was completed at 90 days; 56% showed aesthetic improvement. Overall improvement in SGAIS was 83% and 81% at 90 and 180 days, respectively. The overall improvement in PGAIS was 94% at both 90 and 180 days. Patient satisfaction questionnaires showed that 83% noticed improvements in elbow characteristics at 90 days, with 81% still indicating improvement at 180 days. No serious AEs or treatment-related AEs were reported.CONCLUSIONThis pilot study suggests that MFU-V is a safe and promising nonsurgical option for the treatment of skin laxity above the elbow. Based on the positive results of this study, a larger trial is warranted together with testing different treatment densities to optimize this noninvasive approach.
AB - BACKGROUNDWith the increased popularity of minimally invasive cosmetic treatments, this study evaluates the efficacy and safety of microfocused ultrasound with visualization (MFU-V) for tightening lax skin above the elbow.METHODSSubjects were treated bilaterally above the elbows with MFU-V using transducers with different focal depths. Photographs were taken before treatment and at 90- and 180-day follow-ups. Masked observer ratings and physician and subject global aesthetic improvement scales (PGAIS and SGAIS) were completed at follow-ups. Safety, based on adverse event (AE) incidence, was assessed.RESULTSMasked blinded assessment was completed at 90 days; 56% showed aesthetic improvement. Overall improvement in SGAIS was 83% and 81% at 90 and 180 days, respectively. The overall improvement in PGAIS was 94% at both 90 and 180 days. Patient satisfaction questionnaires showed that 83% noticed improvements in elbow characteristics at 90 days, with 81% still indicating improvement at 180 days. No serious AEs or treatment-related AEs were reported.CONCLUSIONThis pilot study suggests that MFU-V is a safe and promising nonsurgical option for the treatment of skin laxity above the elbow. Based on the positive results of this study, a larger trial is warranted together with testing different treatment densities to optimize this noninvasive approach.
UR - http://www.scopus.com/inward/record.url?scp=84936869796&partnerID=8YFLogxK
U2 - 10.1097/DSS.0000000000000390
DO - 10.1097/DSS.0000000000000390
M3 - Article
C2 - 26066616
AN - SCOPUS:84936869796
SN - 1076-0512
VL - 41
SP - 821
EP - 826
JO - Dermatologic Surgery
JF - Dermatologic Surgery
IS - 7
ER -